Moreover, we have reported a combined effect of the inhibitors of USP7 and PARP enzymes in the treatment of lung neuroendocrine tumor cells expressing USP7 and CCDC6 proteins [23]. The gene discussed is PARP1; the disease is lung neuroendocrine neoplasm.